Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 17.12% vs 10.78% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -41.76% vs 325.06% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 16.54% vs 27.38% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -22.32% vs -6.67% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Astellas Pharma, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -5.83% vs 8.94% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 17.12% vs 10.78% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -56.52% vs 26.65% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -41.76% vs 325.06% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -26.25% vs 12.20% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 16.54% vs 27.38% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 24.08% vs -9.17% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -22.32% vs -6.67% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






